Flyer

Annals of Clinical and Laboratory Research

  • ISSN: 2386-5180
  • Journal h-index: 16
  • Journal CiteScore: 5.60
  • Journal Impact Factor: 4.86
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
+44 7460731551
Awards Nomination
Indexed In
  • Genamics JournalSeek
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • Directory of Research Journal Indexing (DRJI)
  • Publons
  • Euro Pub
  • Google Scholar
  • SHERPA ROMEO
  • Secret Search Engine Labs
Share This Page

Abstract

Growth Hormone Deficit as a First Clinical Manifestation of Early Diffuse Cerebral Glioma in Patient with Neurofibromatosis

Iezzi ML, Varriale G, Zagaroli L, Greco M, Lasorella S and Verrotti di Pianella A

We presented the case of a 2 years old girl who showed a delay of growth and anorexia. On the examination, the child showed cafè-au-lait spots, altered positioning of the toes of the left foot, squint right eye, and epicanthic folds. Two tests confirmed Growth Hormone (GH) deficiency and genetic test for neurofibromatosis was suggested. The child presented a worsening of anorexia and several crises of hypotonia. MRI brain scan showed a diffuse cerebral glioma. Our case was unusual in presenting of glioma, with a very aggressive course at younger age with involvement of the optic radiations requiring radiotherapy for the same. We would like to point up to the importance of a thorough systemic evaluation of any child presenting with short stature, because the child's arrested growth was the clinical sign that led the parents to consult a specialized center and this triggered a series of diagnostic tests based on the visit and the family's history. Moreover, it is important to stress that MRI is a basic step in the diagnostic pathway of GHD because it can detect organic causes of disease, in particular, the presence of intracranial tumors, as in our case report.